# Eli Lilly and Company (LLY) — Q2-2025 Earnings Results

**Report date:** 2025-08-07 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2025

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 14.14%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.31 | N/A | +14.08% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Eli Lilly reported a strong EPS that exceeded expectations, but the stock fell significantly by 14.14%. This decline may reflect investor concerns or broader market reactions, as no revenue figures or management commentary were provided to clarify the results.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2025_